Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the proportion of Rheumatoid Arthritis (RA) subjects
achieving a "good" or "moderate" DAS28 response (EULAR28 criteria) at Week 16 with etanercept
50 mg subcutaneously (SC) once weekly in patients who have failed infliximab.